Last reviewed · How we verify

NCT03409653

Complex Chronic Diseases Program Data Registry

Status unknown Last updated 8 February 2023
What this trial tests

trial in Fibromyalgia in 1,300 participants. Status unknown.

Timeline
12 June 2017
Primary endpoint
30 September 2022
30 September 2025

Quick facts

Lead sponsorBC Women's Hospital & Health Centre
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,300
Start date12 June 2017
Primary completion30 September 2022
Estimated completion30 September 2025
Sites1 location across Canada

Conditions studied

Sponsor

BC Women's Hospital & Health Centre

Who can join

18 and older, any sex, with Fibromyalgia or Chronic Fatigue Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this data registry is to prospectively collect data from patients referred to an Complex Chronic Diseases Program (CCDP) at BC Women's Hospital + Health Centre to assess the quality of life of the CCDP Patients before, during and after their care at the CCDP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other BC Women's Hospital & Health Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03409653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing